Lgl2 Executes Its Function as a Tumor Suppressor by Regulating ErbB Signaling in the Zebrafish Epidermis
Open Access
- 13 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 5 (11) , e1000720
Abstract
Changes in tissue homeostasis, acquisition of invasive cell characteristics, and tumor formation can often be linked to the loss of epithelial cell polarity. In carcinogenesis, the grade of neoplasia correlates with impaired cell polarity. In Drosophila, lethal giant larvae (lgl), discs large (dlg), and scribble, which are components of the epithelial apico-basal cell polarity machinery, act as tumor suppressors, and orthologs of this evolutionary conserved pathway are lost in human carcinoma with high frequency. However, a mechanistic link between neoplasia and vertebrate orthologs of these tumor-suppressor genes remains to be fully explored at the organismal level. Here, we show that the pen/lgl2 mutant phenotype shares two key cellular and molecular features of mammalian malignancy: cell autonomous epidermal neoplasia and epithelial-to-mesenchymal-transition (EMT) of basal epidermal cells including the differential expression of several regulators of EMT. Further, we found that epidermal neoplasia and EMT in pen/lgl2 mutant epidermal cells is promoted by ErbB signalling, a pathway of high significance in human carcinomas. Intriguingly, EMT in the pen/lgl2 mutant is facilitated specifically by ErbB2 mediated E-cadherin mislocalization and not via canonical snail–dependent down-regulation of E-cadherin expression. Our data reveal that pen/lgl2 functions as a tumor suppressor gene in vertebrates, establishing zebrafish pen/lgl2 mutants as a valuable cancer model. In metazoans, the body surface and linings of several organs are formed from membranous tissue called epithelia. The functions of epithelia include secretion, absorption, and protection. Epithelial cells exhibit polarized distribution of several proteins, which is essential for their function. In carcinomas, which are cancers of epithelial origin, this epithelial cell polarity is impaired. Intriguingly, defects in cell polarization can also lead to tumorigenesis in some animal model systems. It is thus important to understand how cell polarization and epithelial growth control are linked so as to treat the carcinomas better by identifying new drug targets. Here we show that in zebrafish a gene named lethal giant larvae 2 (lgl2), which is essential for the establishment of epithelial cell polarity, also acts as a suppressor of malignant growth properties in the epidermis, an epithelial component of the skin. We further show that in absence of lgl2 function increased epidermal growth factor receptor activity imparts malignant properties to the epidermal cells. Thus, we report here a mechanism by which epithelial cells acquire malignant characteristics when cell polarity is impaired in absence of lgl2 function.Keywords
This publication has 72 references indexed in Scilit:
- Numb regulates cell–cell adhesion and polarity in response to tyrosine kinase signallingThe EMBO Journal, 2009
- The Polarity Protein Par6 Induces Cell Proliferation and Is Overexpressed in Breast CancerCancer Research, 2008
- New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrityProceedings of the National Academy of Sciences, 2008
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional PathwaysCancer Research, 2008
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000
- The Hallmarks of CancerCell, 2000
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987